News
The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...
Pricey prescriptions and nagging medical costs are swamping some insurers and employers, which means patients may start ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...
Novo Nordisk (NYSE: NVO) is a Danish pharma heavyweight currently trading at undervalued levels, presenting an attractive ...
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
The company raised its full-year revenue guidance from a range of $58 billion to $61 billion to a range of $60 billion to $62 ...
Some of the losses are down to pharma's broader problems: notably, President Trump's tariff and price-cut threats. But there ...
The people of Northern Gaza are starving. That’s according to an official declaration by a United Nations-backed group of ...
In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For ...
Serena Williams sat down with the hosts of Today for a candid interview about her use of GLP-1 medication. The Olympic ...
Serena Williams revealed she has been taking a GLP-1 medication as part of her weight loss journey. In newly published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results